Yi Ling Teo

805 total citations
11 papers, 625 citations indexed

About

Yi Ling Teo is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Yi Ling Teo has authored 11 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Yi Ling Teo's work include Renal cell carcinoma treatment (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Yi Ling Teo is often cited by papers focused on Renal cell carcinoma treatment (4 papers), Chronic Myeloid Leukemia Treatments (3 papers) and PI3K/AKT/mTOR signaling in cancer (3 papers). Yi Ling Teo collaborates with scholars based in Singapore, Sweden and Australia. Yi Ling Teo's co-authors include Alexandre Chan, Han Kiat Ho, Jo A. Van Ginderachter, Josephine Lum, Jinmiao Chen, Thomas Paulraj Thamboo, Michael Poidinger, Francesca Zolezzi, Subhra K. Biswas and Manesh Chittezhath and has published in prestigious journals such as Journal of Clinical Oncology, Immunity and Breast Cancer Research and Treatment.

In The Last Decade

Yi Ling Teo

11 papers receiving 608 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yi Ling Teo Singapore	9	262	228	150	130	102	11	625
M. Ravic United Kingdom	14	398 1.5×	299 1.3×	198 1.3×	92 0.7×	106 1.0×	36	973
Dennis A. Noe United States	16	256 1.0×	333 1.5×	169 1.1×	69 0.5×	46 0.5×	32	871
Emiko Sugiyama Japan	15	395 1.5×	257 1.1×	78 0.5×	125 1.0×	210 2.1×	32	1.0k
Marisa Cañadas‐Garre Spain	19	256 1.0×	435 1.9×	101 0.7×	175 1.3×	43 0.4×	44	1.0k
Rebecca R. Thomas United States	10	562 2.1×	253 1.1×	56 0.4×	110 0.8×	58 0.6×	10	897
Anja Henningsson Sweden	8	567 2.2×	197 0.9×	45 0.3×	84 0.6×	182 1.8×	12	889
Mohamed Elmeliegy United States	16	583 2.2×	304 1.3×	48 0.3×	289 2.2×	86 0.8×	52	944
Alex Bell United Kingdom	10	189 0.7×	354 1.6×	80 0.5×	71 0.5×	43 0.4×	12	637
Helen Tomkinson United Kingdom	13	178 0.7×	144 0.6×	51 0.3×	105 0.8×	37 0.4×	40	447
Frans L. Opdam Netherlands	15	390 1.5×	356 1.6×	38 0.3×	153 1.2×	76 0.7×	58	782

Countries citing papers authored by Yi Ling Teo

Since Specialization

Citations

This map shows the geographic impact of Yi Ling Teo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yi Ling Teo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yi Ling Teo more than expected).

Fields of papers citing papers by Yi Ling Teo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yi Ling Teo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yi Ling Teo. The network helps show where Yi Ling Teo may publish in the future.

Co-authorship network of co-authors of Yi Ling Teo

This figure shows the co-authorship network connecting the top 25 collaborators of Yi Ling Teo. A scholar is included among the top collaborators of Yi Ling Teo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yi Ling Teo. Yi Ling Teo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Teo, Yi Ling, et al.. (2021). Sustaining a Hotel Business during Crisis: A Singapore Luxury Hotel's Journey during COVID-19. Figshare. 6. 1–20. 2 indexed citations

Chae, Jung‐woo, Yi Ling Teo, Han Kiat Ho, et al.. (2016). BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing regimen. Cancer Chemotherapy and Pharmacology. 78(3). 623–632. 9 indexed citations

Chittezhath, Manesh, Manprit Kaur Dhillon, Damya Laoui, et al.. (2014). Molecular Profiling Reveals a Tumor-Promoting Phenotype of Monocytes and Macrophages in Human Cancer Progression. Immunity. 41(5). 815–829. 217 indexed citations

Teo, Yi Ling, Min‐Han Tan, Ravindran Kanesvaran, et al.. (2014). Association of drug exposure with toxicity and clinical response in metastatic renal cell carcinoma patients receiving an attenuated dosing regimen of sunitinib. Targeted Oncology. 10(3). 429–437. 25 indexed citations

Teo, Yi Ling, Han Kiat Ho, & Alexandre Chan. (2014). Formation of reactive metabolites and management of tyrosine kinase inhibitor-induced hepatotoxicity: a literature review. Expert Opinion on Drug Metabolism & Toxicology. 11(2). 231–242. 58 indexed citations

Teo, Yi Ling, Han Kiat Ho, & Alexandre Chan. (2014). Metabolism‐related pharmacokinetic drug−drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations. British Journal of Clinical Pharmacology. 79(2). 241–253. 139 indexed citations

Teo, Yi Ling, Min‐Han Tan, Ravindran Kanesvaran, et al.. (2013). Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation. Cancer Chemotherapy and Pharmacology. 73(2). 381–388. 14 indexed citations

Teo, Yi Ling, Noan‐Minh Chau, Min‐Han Tan, et al.. (2013). Association of drug exposure with clinical response and toxicities in metastatic renal cell carcinoma patients (mRCC) receiving an alternative dosing (AD) regimen of sunitinib.. Journal of Clinical Oncology. 31(15_suppl). e13582–e13582. 1 indexed citations

Teo, Yi Ling, Han Kiat Ho, & Alexandre Chan. (2012). Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis. Cancer Treatment Reviews. 39(2). 199–206. 73 indexed citations

10.

Teo, Yi Ling, et al.. (2012). Effect of CYP3A4 inducer dexamethasone on hepatotoxicity of lapatinib: clinical and in vitro evidence. Breast Cancer Research and Treatment. 133(2). 703–711. 54 indexed citations

11.

Chan, Vincent, Andrew Fenning, Scott P. Levick, et al.. (2011). Cardiovascular Changes During Maturation and Ageing in Male and Female Spontaneously Hypertensive Rats. Journal of Cardiovascular Pharmacology. 57(4). 469–478. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact